Review Articles
Vol. 3 No. 1 (2011): Reviews, Articles, Case Reports and Letters

EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: October 24, 2011
5126
Views
967
Downloads
2545
HTML
Hematology

Authors

Distinct epidemiological characteristics have been described in Acute Promielocytic Leukemia (APL). Populations from Latin America have a higher incidence of APL and in some geographic areas a distinct distribution of the PML-RARA isoforms is present. Here, we review the main differences in APL epidemilogy in Latin America as well as treatment outcomes.

Downloads

Download data is not yet available.

Citations

Ethics Approval

Review Articles
Eduardo Magalhães Rego, National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology/Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo,
    1   Corresponding author: Eduardo Magalhães Rego, Division of Oncology/Hematology, Department of Internal Medicine; Medical School of Ribeirão Preto, University of São Paulo, Av. Bandeirantes 3900, CEP 14049-900, Ribeirão Preto, SP, Brazil. Phone: (55)(16) 36022888, Fax: (55)(16) 36336695. Email: emrego@hcrp.fmrp.usp.br

How to Cite



“EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA” (2011) Mediterranean Journal of Hematology and Infectious Diseases, 3(1), p. e2011049. doi:10.4084/mjhid.2011.049.